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ABSTRACT
Although the association of some ribosomal protein genes with colorectal cancer is widely known, the detailed mechanisms
and complete list of associated genes is lacking. More importantly, the behaviours of these genes in different types and
stages of the cancer are poorly understood. Herein we report the study of two ribosomal protein genes in cell lines derived
from different sites and stages of colon cancer. Specifically, we analysed the expression pattern of eL14 and uS19 in HCT116
and SW480 cell lines. These two genes, although associated with a wide variety of cancer types, are poorly or have not been
studied in colorectal cancer. Semi-quantitative reverse transcription – polymerase chain reaction (RT-PCR) approach was
used, together with Students’ t-test validation. We found a significantly (p < 0.05) differential eL14 and uS19 expression
patterns between HCT116 and SW480 cell lines. Our findings suggest that eL14 and uS19 have higher activity in a poorly
differentiated cell line derived from advanced (metastatic) stage (Duke’s Stage D) colorectal carcinoma tissues compared to
the moderately differentiated cell line derived from a mid-stage (Duke’s Stage B) colorectal adenocarcinoma tumour. This
will have important implications for both ribosomal protein genes as type and stage specific biomarkers for colon cancer.
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INTRODUCTION
Differential expression of ribosomal protein (RP)
genes is widely reported in a variety of cancer types.
Over the years, there is increasing evidence of their
association with colorectal cancer (Pogue-Geile et
al., 1991; Kondoh et al., 1992; Wang et al., 2000;
Shenoy et al., 2012; Yu et al., 2019). Patterns of
their expression also varies with different stages of
malignancy (Lai & Xu, 2007), thus substantiating
their involvement in the carcinogenesis of colon
cancer. While some RP genes have elevated
expression in colorectal cancer (CRC), several others
are down-regulated, particularly in metastatic CRC
(Lai & Xu, 2007). These RP genes are suspected to
have specific roles in tumour progression and cancer
metastasis, and cellular differentiation in CRC (Gou
et al., 2010). However, not enough is known about
the whole list of RP genes that is associated with
CRC. Current literature lists at least 80 members of
the RP gene family in existence (Ban et al., 2014).
Exactly how many and which of these are linked to
colorectal cancer is yet to be clarified. At what stages
of the cancer are they most active also remains to
be fully elucidated.
We sought to study the ribosomal protein gene
L14 (eL14) in the context of colorectal carcinoma
because its link to the different stages of
malignancy of the cancer has never been properly
studied. eL14 is located at a chromosomal position
3p21.3 (Huang et al., 2006) – a region where the
loss of heterozygosity (LOH) is associated with
several types of cancer, and possibly have tumour
suppressor genes (Liu et al., 2003). eL14 has been
found to be differentially expressed in lung, oral,
(Shriver et al., 1998), oesophageal (Huang et al.,
2006), and nasopharyngeal (Sim et al., 2018)
cancers. More importantly, it is strongly correlated
to microsatellite instability in CRC cases (Yu et al.,
2019). In the case of RP gene S15 (uS19), despite
